{"id":"W2752063004","doi":"10.1136/annrheumdis-2001.1216","title":"OP0086 The fully human anti-tnf monoclonal antibody, adalimumab (d2e7), dose ranging study: the 24-week clinical results in patients with active ra on methotrexate therapy (the armada trial)","year":2001,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"ca_institutions":"Sinai Health System","funders":"","keywords":"Adalimumab; Medicine; Rheumatoid arthritis; Methotrexate; Placebo; Internal medicine; Adverse effect; Dose-ranging study; Refractory (planetary science); Gastroenterology; Surgery; Double blind; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001400316,0.001805067,0.002931563,0.00035917,0.0003346686,0.001151736,0.0008107967,0.001744567,0.004038724],"category_scores_gemma":[0.001520558,0.0005578056,0.001502676,0.000322187,0.0008146034,0.0008540415,0.0003866807,0.004093266,0.001286508],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003671603,"about_ca_system_score_gemma":0.0004851937,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000548589,"about_ca_topic_score_gemma":0.001443202,"domain_scores_codex":[0.9995804,0.0002507513,0.00001427409,0.00004785375,0.00003714073,0.00006949319],"domain_scores_gemma":[0.9993512,0.0001809363,0.0001412943,0.00006083933,0.00002931093,0.0002364572],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9229695,0.0041484,0.001653393,0.0009911673,0.001444626,0.0001594912,0.00009926608,0.001078417,0.008296757,0.0003231885,0.00626448,0.05257127],"study_design_scores_gemma":[0.9395939,0.04971061,0.005643122,0.00004601751,0.0006009137,0.0001803952,0.0000261553,0.0003919169,0.0005138451,0.0002370705,0.003030368,0.00002560376],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9716889,0.01439395,0.0008617363,0.001582084,0.0007210793,0.0009954388,0.003470268,0.0003598715,0.005926696],"genre_scores_gemma":[0.9699176,0.006462498,0.00221125,0.002472759,0.0009316994,0.001676937,0.004945694,0.00009018046,0.01129125],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004038724,"threshold_uncertainty_score":0.01351088,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1407855603457767,"score_gpt":0.4322839467827096,"score_spread":0.2914983864369329,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}